Obermatt

Senseonics

NSQ:SENS · US81727U3032
Health Care Equipment & SuppliesSmall

360

7
Profit price51
Owner Earnings Yield1
Dividend Yield1
Price/Sales19
EV / Gross Profit9
Price/Book85
Return on Capital5
Cash Return on Capital8
Return on Equity5
EBIT Margin8
Gross Profitability10
Accruals3
Owner Earnings Margin12
Sales growth96
Profit growth12
Reinvestment65
Price momentum22
Debt load42
Refinancing38
Debt Payback1
Liquidity14
Analyst ratings39
Opinion Changes13
Price Target Upside85
Market mood53
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Senseonics doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Employees201
ISINUS81727U3032
Last UpdateApr 2, 2026
Themes
Health DiagnosticsMHealthDiabetesEndocrinologySensorsBiomedical EngineeringDetectors, Sensors and MemsWearables

Description

Senseonics Holdings, Inc. operates as a medical technology company. The company focuses on the development and commercialization of a long-term, implantable continuous glucose monitoring (‘CGM’) system to improve the lives of people with diabetes by…

Analysis

Story stock

Senseonics Holdings, Inc. is a story stock: the narrative is ambitious and the price reflects it, but the underlying numbers are weak.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 6/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
11
2026

All-time high

15

Mar 2026

All-time low

11

Jun 2026

Average rank

13

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
19
Price/Earnings
67
Price/Book
85
Dividend Yield
1
Value (overall)
50

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Senseonics with its peers
Cardiol Therapeutics
TOR:CRDL
81
CountryCanada
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Sharps Technology
NAQ:STSS
56
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Verrica Pharmaceuticals
NAQ:VRCA
55
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
First Interstate Bancsystem
NSQ:FIBK
19
CountryUSA
IndustryBanks
SizeSmall
Full Stock Analysis →
Rhythm Pharmaceuticals
NMQ:RYTM
31
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Pioneer Power Solutions
NAQ:PPSI
16
CountryUSA
IndustryElectrical Equipment
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →